Mural Oncology Q4 EPS $(3.57) Down From $(2.91) YoY, Cash Balance of $270.9M
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.